Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.6 (
CAD
)
4,420
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apoptotic cell death is characterized by several morphological nuclear changes, such as chromatin condensation and extensive fragmentation of chromosomal DNA. These alterations are primarily triggered through the activation of caspases, which subsequently cleave nuclear substrates. Caspase-3 induces processing of Acinus, which leads to chromatin condensation. DNA fragmentation is dependent on the DNase
CAD
, which is released from its inhibitor, ICAD, upon cleavage by caspase-3. DNA degradation is also induced by AIF and endonuclease G, which are both released from mitochondria upon death stimuli but do not require prior processing by caspases for their DNase activity. Here we report the identification of a widely expressed helicase designated
Helicard
, which contains two N-terminal CARD domains and a C-terminal helicase domain. Upon apoptotic stimuli,
Helicard
is cleaved by caspases, thereby separating the CARD domains from the helicase domain. While
Helicard
localizes in the cytoplasm, the helicase-containing fragment is found in the nucleus.
Helicard
accelerates Fas ligand-mediated DNA degradation, whereas a noncleavable or a helicase-dead
Helicard
mutant does not, implicating
Helicard
in the nuclear remodeling occurring during apoptosis.
...
PMID:Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation. 1201 21